News

Ventrus has submitted a new SPA that includes a revised protocol, including the newly defined endpoints, in accordance with the feedback received from that meeting, and expects a

The deal expands BD’s presence into the emerging affordable personal flow cytometer space, and also expands the use of flow cytometry technology. BD Biosciences president William Rhodes said

The screening panels allow researchers to simultaneously examine key genes that are associated with X-chromosome disorders and syndromic forms of Autism Spectrum Disorder (ASD). The RainDance ASDSeq and

The active substance of Yellox is bromfenac, an anti-inflammatory agent, non-steroids, ATC code: S01BC11, with mechanism of action through blockage of the prostaglandin synthesis by inhibiting primarily cyclooxygenase

Teva Pharma said that the positive opinion was based on the significant results from the clinical trials evaluating, NOMAC-E2. NOMAC-E2 is a monophasic regimen containing an estrogen which

Avid, a wholly-owned subsidiary of Eli Lilly. Lilly acquired Avid Radiopharmaceuticals in December 2010. Amyvid is a molecular imaging agent under investigation for Positron Emission Tomography (PET) imaging

The company has posted loss from operations of $6.2m, compared to $3.26m for the comparable period in 2009. For the full year ended 31 December 2010, the company

The advancement follows the receiving of $40m by FibroGen from its partner Astellas in the fourth quarter of 2010 under Astellas’ license to rights for the European Union

Xyrem is an oral solution that contains the active substance sodium oxybate (500mg/ml). Xyrem is indicated for the treatment of narcolepsy with cataplexy in adults. UCB said that